Exploring Cell Therapies in HER2 Solid Tumors

Time: 9:00 am
day: Day Two

Details:

• Discussing target engagement and response biomarkers
• Targeting tumors, targeted therapies & more
• Exploring T cell Antigen Coupler (TAC) technology